INSIDER · CIK 1274139
Hershberg Robert
Director at RECURSION PHARMACEUTICALS, INC. (RXRX) · Director at Adaptive Biotechnologies Corp (ADPT)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$873KSold on the market
2Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202618:08 | Oct 6, 2026 | RXRXRECURSION PHARMACEUTICALS, INC. | Director | S · Sell10b5-1 | $5.00 | −25,000 | 162,156 | -13% | −$125K | ||
| Oct 7, 202618:08 | Oct 6, 2026 | RXRXRECURSION PHARMACEUTICALS, INC. | Director | M · Exercise10b5-1 | $2.22 | +25,000 | 187,156 | +15% | $56K | ||
| Aug 20, 202617:55 | Aug 18, 2026 | ADPTAdaptive Biotechnologies Corp | Director | S · Sell | $24.40 | −30,664 | 46,683 | -40% | −$748K | ||
| Aug 20, 202617:55 | Aug 18, 2026 | ADPTAdaptive Biotechnologies Corp | Director | M · Exercise | $6.32 | +15,000 | 77,347 | +24% | $95K |